Search research articles
Contact Us
Filters
Showing results (501-510 of 596) with videos related to
Page
of 60
Sort By:
JCO Precision Oncology
|
June 7, 2021
Serial Monitoring of Circulating Tumor DNA by Next-Generation Gene Sequencing as a Biomarker of Response and Survival in Patients With Advanced NSCLC Receiving Pembrolizumab-Based Therapy
Jeffrey C Thompson, Erica L Carpenter, Benjamin A Silva, et al.
Science (New York, N.Y.)
|
June 20, 2024
Combined JAK inhibition and PD-1 immunotherapy for non-small cell lung cancer patients
Divij Mathew, Melina E Marmarelis, Caitlin Foley, et al.
JTO Clinical and Research Reports
|
April 8, 2022
Plasma Genotyping at the Time of Diagnostic Tissue Biopsy Decreases Time-to-Treatment in Patients With Advanced NSCLC-Results From a Prospective Pilot Study
Jeffrey C Thompson, Charu Aggarwal, Janeline Wong, et al.
Clinical Lung Cancer
|
April 19, 2023
Utilization and Factors Precluding Receipt of Checkpoint Inhibitor Consolidation for Stage III NSCLC in a Large US Academic Health System
Nikhil Yegya-Raman, Cole Friedes, Lova Sun, et al.
Journal of Geriatric Oncology
|
April 5, 2021
The impact of age on outcome in phase III NRG Oncology/RTOG trials of radiotherapy (XRT) +/- systemic therapy in locally advanced head and neck cancer
Julie A Kish, Qiang Zhang, Corey J Langer, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 31, 2023
Phase 2 Trial of Consolidation Pembrolizumab After Proton Reirradiation for Thoracic Recurrences of Non-Small Cell Lung Cancer
Nikhil Yegya-Raman, Abigail T Berman, Christine A Ciunci, et al.
Cancer
|
January 31, 2024
Acute hospitalizations after proton therapy versus intensity-modulated radiotherapy for locally advanced non-small cell lung cancer in the durvalumab era
Michelle Iocolano, Nikhil Yegya-Raman, Cole Friedes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 6, 2017
Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial
Dong-Wan Kim, Marcello Tiseo, Myung-Ju Ahn, et al.
JCO Oncology Practice
|
July 3, 2024
Electronic Medical Record-Based Nudge Intervention to Increase Comprehensive Molecular Genotyping in Patients With Metastatic Non-Small Cell Lung Cancer: Results From a Prospective Clinical Trial
Melina E Marmarelis, Dylan G Scholes, Tara L McWilliams, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 13, 2016
Pilot and Feasibility Trial Evaluating Immuno-Gene Therapy of Malignant Mesothelioma Using Intrapleural Delivery of Adenovirus-IFNα Combined with Chemotherapy
Daniel H Sterman, Evan Alley, James P Stevenson, et al.
Page
of 60
Search research articles
Search
Showing results (501-510 of 596) with videos related to
Sort By:
Page
of 60
JCO Precision Oncology
|
June 7, 2021
Serial Monitoring of Circulating Tumor DNA by Next-Generation Gene Sequencing as a Biomarker of Response and Survival in Patients With Advanced NSCLC Receiving Pembrolizumab-Based Therapy
Jeffrey C Thompson, Erica L Carpenter, Benjamin A Silva, et al.
Science (New York, N.Y.)
|
June 20, 2024
Combined JAK inhibition and PD-1 immunotherapy for non-small cell lung cancer patients
Divij Mathew, Melina E Marmarelis, Caitlin Foley, et al.
JTO Clinical and Research Reports
|
April 8, 2022
Plasma Genotyping at the Time of Diagnostic Tissue Biopsy Decreases Time-to-Treatment in Patients With Advanced NSCLC-Results From a Prospective Pilot Study
Jeffrey C Thompson, Charu Aggarwal, Janeline Wong, et al.
Clinical Lung Cancer
|
April 19, 2023
Utilization and Factors Precluding Receipt of Checkpoint Inhibitor Consolidation for Stage III NSCLC in a Large US Academic Health System
Nikhil Yegya-Raman, Cole Friedes, Lova Sun, et al.
Journal of Geriatric Oncology
|
April 5, 2021
The impact of age on outcome in phase III NRG Oncology/RTOG trials of radiotherapy (XRT) +/- systemic therapy in locally advanced head and neck cancer
Julie A Kish, Qiang Zhang, Corey J Langer, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 31, 2023
Phase 2 Trial of Consolidation Pembrolizumab After Proton Reirradiation for Thoracic Recurrences of Non-Small Cell Lung Cancer
Nikhil Yegya-Raman, Abigail T Berman, Christine A Ciunci, et al.
Cancer
|
January 31, 2024
Acute hospitalizations after proton therapy versus intensity-modulated radiotherapy for locally advanced non-small cell lung cancer in the durvalumab era
Michelle Iocolano, Nikhil Yegya-Raman, Cole Friedes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 6, 2017
Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial
Dong-Wan Kim, Marcello Tiseo, Myung-Ju Ahn, et al.
JCO Oncology Practice
|
July 3, 2024
Electronic Medical Record-Based Nudge Intervention to Increase Comprehensive Molecular Genotyping in Patients With Metastatic Non-Small Cell Lung Cancer: Results From a Prospective Clinical Trial
Melina E Marmarelis, Dylan G Scholes, Tara L McWilliams, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 13, 2016
Pilot and Feasibility Trial Evaluating Immuno-Gene Therapy of Malignant Mesothelioma Using Intrapleural Delivery of Adenovirus-IFNα Combined with Chemotherapy
Daniel H Sterman, Evan Alley, James P Stevenson, et al.
Page
of 60